Glenmark Pharmaceuticals | Glenmark Pharma | Glenmark Pharmaceuticals Share Price | Glenmark Pharma Share Price
Drug major Glenmark Pharmaceuticals on Wednesday plunged over 10% on the Bombay Stock Exchange (BSE), a day after a GSK unit filed a patent infringement lawsuit on the company’s subsidiary Glenmark Generics Inc in a US District Court.
Shares of Glenmark Pharmaceuticals plunged 10.60 % to Rs 233.85 on the BSE while the scrip plunged to a low of Rs 215, down 17.79 per cent on the NSE.